KateBramham King's College LondonUnited Kingdom

KateBramham
Dr Kate Bramham is passionate about addressing health inequalities and is committed to changing the trajectory of kidney disease and cardiovascular health, particularly in Black communities, for women and those with mental health difficulties. She has authored >150 original manuscripts and book chapters on renal disease, ethnicity and pregnancy and has contributed to national and international guidelines. Her work focuses on improving the detection and prevention of early kidney disease through community-led, point-of-care, and digital inclusion approaches, and developing novel treatments to protect kidney function in people of African ancestry and during pregnancy. She is the Chief Investigator for several multi-centre NIHR, UKRI and charity funded studies and holds >£12m grant funding addressing health inequalities in the UK and Africa.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/66423695b4099bfd3c950f8c86257ec7.jpg
First Name
Kate
Last Name
Bramham
Institution
Country.
United Kingdom

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
Navigating Pregnancy and Kidney Disease: Risks, Benefits, and Global Insights. ISN-WIN/WIN India Joint Session
LizLightstone Chair Imperial College LondonUnited Kingdom
RashaDarwish Chair Kasr Aleiny medical school , Cairo UniversityEgypt
UrmilaAnandh Chair Amrita Hospitals, Faridabad, Delhi NCRIndia
  • Patient Presentation
  • Pregnancy-related AKI – a Lethal Problem
    DIVYABAJPAI Speaker Professor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, IndiaIndia
  • aHUS in Pregnancy - What Do We Know and What Can We Do?
    AnujaJava Speaker WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States
  • Using Pregnancy to Initiate Long-term Kidney Care for Women
    SaraladeviNaicker Speaker University of the Witwatersrand South Africa
  • Developmental Origins of Kidney Disease: It’s All About Mother
    KateBramham Speaker King's College LondonUnited Kingdom
  • Panel Discussion with Speakers: How to Change Things? How to Raise Awareness?
Gulmohar Hall 302

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
HIT! High Impact Clinical Trials – Why and How
DavidWheeler Chair University College LondonUnited Kingdom
Winston Wing ShingFung Chair Prince of Wales Hospital, Hong KongHong Kong, China
  • What Have We Learned From CONVINCE?
    PeterBlankestijn Oral Abstract Presenter University Medical Center UtrechtNetherlands
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter University of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    KateBramham Oral Abstract Presenter King's College LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter Associate Professor in Nephrology, Christian Medical College, Vellore, IndiaIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Brahmkamal Hall - Plenary Hall